The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Haas Jason since 2023.
This trader's CIK number is 1883821.
At the time of last reporting, Haas Jason was the Chief Financial Officer of Syros Pharmaceuticals, Inc.. (stock ticker symbol SYRS).
Also see all insider trading activities at Syros Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | SYRS | 100,000 | $161,217 | 137,803 | $28,938 | 34,208 | $0 |
| 2023 | SYRS | 0 | $0 | 0 | $0 | 2,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-18 | SYRS | Sale | 137,803 | .21 | 28,938 |
| 2024-10-31 | SYRS | Option Ex | 18,875 | .00 | 0 |
| 2024-09-12 | SYRS | Buy | 45,344 | 1.68 | 75,996 |
| 2024-09-11 | SYRS | Buy | 19,293 | 1.58 | 30,444 |
| 2024-09-10 | SYRS | Buy | 35,363 | 1.55 | 54,777 |
| 2024-03-31 | SYRS | Option Ex | 15,333 | .00 | 0 |
| 2023-03-31 | SYRS | Option Ex | 2,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Haas Jason (Chief Financial Officer of Syros Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.